Page 103 - Cardiac testing for coronary artery disease in potential kidney transplant recipients
P. 103

(Continued)


                           73. risk stratification.tw.
                           74. risk algorithm.tw.
                           75. (carotid adj2 (ultrasound or ultrasonogra$)).tw.
                           76. (carotid adj2 (media$ intima$ thickness or intima$ media$ thickness)).tw.
                           77. or/28-76
                           78. and/16,27,77


                Appendix 2. QUADAS methodological items and operational definitions




                 Methodological variable                  Operational definition/information required from each study


                 1. Representative spectrum (spectrum bias)  When included patients did not represent the intended targeted popu-
                                                          lation, this may have led to an under- or overestimation of diagnostic
                                                          accuracy depending on the difference between the targeted and included
                                                          populations. The target spectrum in our review was patients with renal
                                                          failure who were candidates for kidney transplantation. This was scored
                                                          ’yes’ if study participants included only patients with kidney disease who
                                                          were considered to be candidates for kidney transplantation

                 2. Acceptable reference standard         An imperfect reference standard may have resulted in misclassification
                                                          of disease positives and disease negatives. For the purpose of this review,
                                                          studies had an acceptable reference standard if they used coronary an-
                                                          giography as the reference standard
                 3. Acceptable delay between tests (disease progression bias)  Disease may have progressed to a more advanced stage (i.e. greater degree
                                                          of coronary artery stenosis) if a significant time interval between index
                                                          and reference tests was observed, thereby leading to disease progression
                                                          bias. This was scored as ‘yes’ if the delay between test was short (i.e. less
                                                          than three months)

                 4. Partial verification avoided (verification bias)  Partial verification bias usually leads to an overestimation of sensitivity,
                                                          although its effect on specificity varies. This item was scored ‘yes’ if all
                                                          patients who received the index test were also evaluated by the reference
                                                          standard
                 5. Differential verification avoided      This was scored ‘yes’ if no patients were verified with a second or third
                                                          reference standard
                 6. Incorporation avoided (incorporation bias)  This bias usually leads to an overestimation of diagnostic test accuracy.
                                                          Incorporation bias was deemed to have existed if the index test was in-
                                                          corporated in a composite reference standard. Studies were scored ‘yes’ if
                                                          their classification of disease status did not directly involve the results of
                                                          the index test






                Cardiac testing for coronary artery disease in potential kidney transplant recipients (Review)  101
                Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
   98   99   100   101   102   103   104   105   106